# A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency

> **NCT07711158** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Shanghai RAAS Blood Products Co., Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Factor VII Deficiency

## Interventions

- **DRUG:** SR604

## Key facts

- **NCT ID:** NCT07711158
- **Lead sponsor:** Shanghai RAAS Blood Products Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-02
- **Final completion:** 2027-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711158, "A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII Deficiency". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*